公开(公告)号：US20220305071A1

公开(公告)日：2022-09-29

申请号：US17699348

申请日：2022-03-21

申请人： OKCHUNDANG CO., LTD.

发明人： Chul Jong JUNG ,  Seok Man PARK ,  Gyung Yeun BEIK ,  Yoeng Eun YU

IPC分类号： A61K36/736 ,  A61P31/02

摘要： Disclosed herein is a composition comprising a Prunus persica extract for skin wrinkle reduction, anti-oxidation, skin regeneration, skin whitening, or wound healing. Exhibiting high effects of skin wrinkle reduction antioxidation, skin regeneration, skin whitening, or wound healing, the Prunus persica extract can find various applications in cosmetic products for skin wrinkle reduction, antioxidation, skin regeneration, skin whitening and medicinal topical formulations for wound healing.

公开(公告)号：US20220233623A1

公开(公告)日：2022-07-28

申请号：US17572943

申请日：2022-01-11

申请人： OKCHUNDANG CO., LTD.

发明人： Chul Jong JUNG ,  Gyung Yeun BEIK

IPC分类号： A61K36/285 ,  A61P17/14

摘要： Disclosed herein are a composition comprising an Aucklandia lappa Decne. extract, especially a crude solvent extract from Aucklandia lappa as an active ingredient for alleviation, inhibition, prevention, or treatment of hair loss, and a preparation method therefor. The Aucklandia lappa Decne. extract can be used in a pharmaceutical or food composition useful for alleviating, inhibiting, preventing, and treating hair loss.

公开(公告)号：US11235018B2

公开(公告)日：2022-02-01

申请号：US16249501

申请日：2019-01-16

申请人： OKCHUNDANG CO., LTD.

发明人： Sae Kwang Ku ,  Seong Min Ku ,  Tae Hun Ku ,  Chui Jong Jung ,  Gyung Yun Beik ,  Jin Gi Shin ,  Sang Soo Lee ,  Jeong Gyun Seo ,  Chil Surk Yoon ,  Xian Li

IPC分类号： A61K36/64 ,  A61K36/258 ,  A61K36/342 ,  A61K36/076 ,  A61K31/5377 ,  A61P35/00 ,  A23L33/105 ,  A61K35/644

摘要： The present invention provides a pharmaceutical composition for preventing or treating cancer, a food composition for enhancing immune functions, and a pharmaceutical composition for preventing or treating cachexia. The composition of the present invention provides effects of further inhibiting the growth of tumors, increasing immunological activity, and suppressing cachexia caused by tumors. In addition, the composition of the present invention can obtain a synergistic effect when co-administered with an existing anticancer drug.

公开(公告)号：US11129861B2

公开(公告)日：2021-09-28

申请号：US15885122

申请日：2018-01-31

申请人： OKCHUNDANG CO., LTD.

发明人： Seong Min Ku ,  Tae Hun Ku ,  Chul Jong Jung ,  Jeong Gyun Seo ,  Hye Ran Gong ,  Sae Kwang Ku ,  Seok Man Park ,  Ryong Kong ,  Xian Li ,  Gyung Yun Beik ,  Yoeng Eun Yu ,  Hee Jeong Ryu ,  Gyu Hyeon Kim

IPC分类号： A61K36/258 ,  A61K36/342 ,  A61P13/12 ,  A61K36/07 ,  A61K36/64 ,  A61K31/70 ,  A61P17/00 ,  A61P37/08 ,  A61P7/00 ,  A61P11/06 ,  A61P27/02 ,  A61P1/02 ,  A61P27/16 ,  A61P1/00 ,  A61P11/00 ,  A61P1/04 ,  A61P15/02 ,  A61P19/06 ,  A61P19/02 ,  A61P29/00 ,  A61P1/16 ,  A61P13/10

摘要： The present invention provides a composition containing, as active ingredients, Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa, and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects.

公开(公告)号：US20220211792A1

公开(公告)日：2022-07-07

申请号：US17564459

申请日：2021-12-29

申请人： OKCHUNDANG CO., LTD.

发明人： Chul Jong JUNG ,  Seok Man PARK ,  Ryong KONG ,  Yoeng Eun YU

IPC分类号： A61K36/64 ,  A61K36/344 ,  A61K36/258 ,  A61K36/346 ,  A61K36/076 ,  A61K36/734 ,  A61K36/481 ,  A61P37/04 ,  A61P31/12

摘要： Disclosed is a composition containing natural extracts for enhancement of innate immunity or antiviral use against influenza virus (PR8) or corona virus, wherein the composition promotes interferon secretion in the innate defense immune system to induce protection from the antiviral infection and thus can be effectively used for antiviral use.

公开(公告)号：US20180214499A1

公开(公告)日：2018-08-02

申请号：US15885122

申请日：2018-01-31

申请人： OKCHUNDANG CO., LTD.

发明人： Seong Min KU ,  Tae Hun KU ,  Chul Jong JUNG ,  Yun Young CHO ,  Jeong Gyun SEO ,  Nam Oh KIM ,  Hee Yoon JEONG ,  Eun Sik CHOI ,  Hye Ran GONG ,  Sae Kwang KU

IPC分类号： A61K36/342 ,  A61K36/258 ,  A61K36/07 ,  A61K36/64 ,  A61K31/70 ,  A61P17/00 ,  A61P37/08 ,  A61P7/00 ,  A61P11/06 ,  A61P27/02 ,  A61P1/02 ,  A61P27/16 ,  A61P1/00 ,  A61P11/00 ,  A61P1/04 ,  A61P15/02 ,  A61P19/06 ,  A61P19/02 ,  A61P29/00 ,  A61P1/16 ,  A61P13/10 ,  A61P13/12

CPC分类号： A61K36/342 ,  A61K31/70 ,  A61K36/07 ,  A61K36/258 ,  A61K36/64 ,  A61P1/00 ,  A61P1/02 ,  A61P1/04 ,  A61P1/16 ,  A61P7/00 ,  A61P11/00 ,  A61P11/06 ,  A61P13/10 ,  A61P13/12 ,  A61P15/02 ,  A61P17/00 ,  A61P19/02 ,  A61P19/06 ,  A61P27/02 ,  A61P27/16 ,  A61P29/00 ,  A61P37/08 ,  A61K2300/00

摘要： The present invention provides a composition containing, as active ingredients, Panax ginseng, Adenophora triphylla, Wolfiporia extensa, Rehmannia glutinosa, and Mel for an antitussive, expectorant, or anti-inflammatory action, and a composition for preventing, alleviating, or treating a respiratory disease. The present invention provides a compositions having excellent effects compared with an existing antitussive agent and expectorant agent. The compositions of the present invention are a naturally derived material and has little cytotoxicity, and thus is expected to be safely used as a medicine or food composition having antitussive, expectorant, and anti-inflammatory effects.